Evidence map›Paper›PMID 36521906›Full record

Observational studyBMJ open2022

Incremental medical cost of delirium in elderly patients with cognitive impairment: analysis of a nationwide administrative database in Japan.

Masakazu Igarashi, Kotoba Okuyama, Naoya Ueda, Hideki Sano, Kanae Takahashi, Zaina P Qureshi, Shigeru Tokita, Asao Ogawa, Yasuyuki Okumura, Shoki Okuda

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Masakazu IgarashiMedical Affairs, MSD KK, Tokyo, Japan.
Kotoba OkuyamaMedical Affairs, MSD KK, Tokyo, Japan.
Naoya UedaMedical Affairs, MSD KK, Tokyo, Japan.
Hideki SanoMedical Affairs, MSD KK, Tokyo, Japan.
Kanae TakahashiJapan Development, MSD KK, Tokyo, Japan.
Zaina P QureshiCenter for Observational and Real-world Evidence (CORE), Merck & Co, Inc, Rahway, New Jersey, USA.
Shigeru TokitaMedical Affairs, MSD KK, Tokyo, Japan.
Asao OgawaDivision of Psycho-Oncology, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Chiba, Japan.
Yasuyuki OkumuraInitiative for Clinical Epidemiological Research, Tokyo, Japan.
Shoki OkudaMedical Affairs, MSD KK, Tokyo, Japan shoki.okuda@merck.com.ORCID 0000-0002-6336-2602
MSD K.K. (Japan) · JPChiba Cancer Center · JPMerck & Co., Inc., Rahway, NJ, USA (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesDelirium is a neuropsychiatric disorder that commonly occurs in elderly patients with cognitive impairment. The economic burden of delirium in Japan has not been well characterised. In this study, we assessed incremental medical costs of delirium in hospitalised elderly Japanese patients with cognitive impairment.

designRetrospective, cross-sectional, observational study.

settingAdministrative data collected from acute care hospitals in Japan between April 2012 and September 2020.

participantsHospitalised patients ≥65 years old with cognitive impairment were categorised into groups-with and without delirium. Delirium was identified using a delirium identification algorithm based on the International Classification of Diseases 10 OUTCOME MEASURES: Total medical costs during hospitalisation were compared between the groups using a generalised linear model.

resultsThe study identified 297 600 hospitalised patients ≥65 years of age with cognitive impairment: 39 836 had delirium and 257 764 did not. Patient characteristics such as age, sex, inpatient department and comorbidities were similar between groups. Mean (SD) unadjusted total medical cost during hospitalisation was 979 907.7 (871 366.4) yen for patients with delirium and 816 137.0 (794 745.9) yen for patients without delirium. Adjusted total medical cost was significantly greater for patients with delirium compared with those without delirium (cost ratio=1.09, 95% CI: 1.09 to 1.10; p<0.001). Subgroup analyses revealed significantly higher total medical costs for patients with delirium compared with those without delirium in most subgroups except patients with hemiplegia or paraplegia.

conclusionsMedical costs during hospitalisation were significantly higher for patients with delirium compared with those without delirium in elderly Japanese patients with cognitive impairment, regardless of patient subgroups such as age, sex, intensive care unit admission and most comorbidities. These findings suggest that delirium prevention strategies are critical to reducing the economic burden as well as psychological/physiological burden in cognitively impaired elderly patients in Japan.

Indexed as

Cognitive DysfunctionDeliriumAgedCross-Sectional StudiesHumansJapanRetrospective StudiesDelirium & cognitive disordersDementiaOld age psychiatry

Identifiers

PMID36521906
PMCPMC9756163
OpenAlexW4311549229

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.